0 Universal vaccines: A holy grail for the flu?
In this blog, we review some of the main targets of universal vaccines and the key challenges to their successful implementation.
Browsing: Viral > Influenza
0 Could obesity promote virulence in influenza?
A mouse study has revealed that obesity may be one factor explaining the significant amount of variation in the influenza virus each year, likely due to an impaired interferon defense response.
0 The lessons of flu blogging
Crawford Kilian tells us about how he got into the world of flu blogging, or ‘Flublogia’ and what he’s learnt from his experiences with this world over the last 15 years.
0 Could wearable devices allow real-time flu prediction?
A study has evaluated de-identified data from wearable devices, discovering that this could improve real-time prediction of flu-like illnesses when compared with current surveillance methods.
0 Immunological imprinting: first flu strain encountered impacts future immune response
The first strain of flu we encounter during childhood could impact our immune responses to future infections, according to new research.
0 WHO prequalifies Ebola vaccine: November’s industry headlines
Take a look at this month’s industry headlines including results for Takeda’s dengue vaccine, approvals for Merck’s Ebola vaccine and the advent of a siderophore antibiotic – the first of this kind.
0 IDWeek: Flu vaccine reduces risk of hospitalization and death
Two analyses supported by the Centers for Disease Control and Prevention’s US influenza data have demonstrated that immunization reduces the risk of hospitalization in children and death in adults
0 US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
0 ECCMID19: Some individuals shed flu virus before symptoms appear
Research presented at ECCMID examining influenza transmission has discovered that a substantial proportion of patients and healthcare workers shed the flu virus before clinical symptoms appear.
0 Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines
Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.
